By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Caladrius Biosciences (Formerly Known As NeoStem, Inc.)  

420 Lexington Ave, Suite 350

New York  New York  10170  U.S.A.
Phone: 212-584-4180 Fax: 425-696-4651




Company News
Caladrius Biosciences Announces Publication Of Two-Year Results From Phase 1 Trial Of Type 1 Diabetes Product Candidate In Science Translational Medicine 12/1/2015 10:25:37 AM
Caladrius Biosciences Presents Additional Data Supporting Lead Product Candidate For Metastatic Melanoma At SITC 2015 11/9/2015 11:44:14 AM
Caladrius Biosciences To Present At Multiple Upcoming November Conferences 11/2/2015 12:05:11 PM
Caladrius Biosciences Announces Management And Board Changes 10/8/2015 7:24:43 AM
Caladrius Biosciences To Present At Multiple Upcoming October Conferences 10/1/2015 8:55:04 AM
Caladrius Biosciences To Present Data Elucidating CLBS20 Mechanism of Action 9/30/2015 7:41:01 AM
Caladrius Biosciences Receives Award From The National Cancer Institute 9/24/2015 10:00:09 AM
Caladrius Biosciences And Sanford Research Establish Strategic Collaboration With Goal Of Developing Major Advance In Treatment Of Type 1 Diabetes 9/22/2015 8:08:15 AM
Caladrius Biosciences To Present At Multiple Upcoming Conferences 9/10/2015 11:06:58 AM
Caladrius Biosciences Announces Second Quarter 2015 Financial Results Conference Call 8/6/2015 3:09:05 PM